MSH|^~\&|MIC|RCH|||202002281100||ORU^R01|4177936|D|2.3|||AL|NE
PID|1||RC00007990|RC7708|PHATEST^LUMED2^||19890901|F||||||||||RC000879/19|
OBR|1|39852^MIC|00030046^20:B0000025R^MIC^20:B25^39852|100.5005^BC^Blood culture^^^600-7||202002261114|202002251113|||||||202002261113|Blood^^^Peripheral|||||||||MB|F||||
OBX|1|CE|100.5010^BCT^Blood culture^^6463-4^600-7^O:SAUR|1.1|SAUR^Staphylococcus aureus||||||F|||202002261119
OBR|2||00030046^20:B0000025R^MIC^20:B25^39852|913.2500^P580^Vitek P580 Sensitivity^^^29576-6||202002261114|202002251113|||||||202002261113|Blood^^^Peripheral|||||||||MB|F|6463-4^1.1|||39852^MIC
OBX|1|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||R|||F|||202002261119
OBX|2|ST|200.600^OX^Cloxacillin^^197-4^197-4|||||R|||F|||202002261119
OBX|3|ST|800.000^VA^Vancomycin^^524-9^524-9|||||S|||F|||202002261119

MSH|^~\&|MIC|RCH|||202002281100||ORU^R01|4177937|D|2.3|||AL|NE
PID|1||RC00007943|RC7677|PHATEST^ITALY^||19991120|M||||||||||RC000767/19|9874855238
OBR|1|39861^MIC|00030055^20:B0000026R^MIC^20:B26^39861|100.5005^BC^Blood culture^^^600-7||202002261141|202002251140|||||||202002261140|Blood^^^Peripheral|||||||||MB|I||||
OBX|1|CE|100.5010^BCT^Blood culture^^6463-4^600-7^O:ECOL|1.1|ECOL^Escherichia coli||||||P|||202002261143
OBX|2|ST|100.5010^BCT^Blood culture^^6463-4^600-7^P:ORGIDSECOM|1.1|||||||P|||202002261143
OBX|3|ST|100.5010^BCT^Blood culture^^6463-4^600-7^R:FSU|1.1|Further susceptibility testing underway.||||||P|||202002261143

MSH|^~\&|MIC|RCH|||202002281100||ORU^R01|4177939|D|2.3|||AL|NE
PID|1||RC00007943|RC7677|PHATEST^ITALY^||19991120|M||||||||||RC000767/19|9874855238
OBR|1|39864^MIC|00030058^20:B0000027R^MIC^20:B27^39864|100.5005^BC^Blood culture^^^600-7||202002261144|202001121143|||||||202002261144|Blood^^^Peripheral|||||||||MB|F||||
OBX|1|CE|100.5010^BCT^Blood culture^^6463-4^600-7^O:ECOLESB|1.1|ECOLESB^Escherichia coli - ESBL||||||F|||202002261150
OBR|2||00030058^20:B0000027R^MIC^20:B27^39864|903.3150^N391^Vitek N391 Sensitivity^^^29576-6||202002261144|202001121143|||||||202002261144|Blood^^^Peripheral|||||||||MB|F|6463-4^1.1|||39864^MIC
OBX|1|ST|100.000^MER^Meropenem^^6652-2^6652-2|||||S|||F|||202002261150
OBX|2|ST|100.500^CAX^Ceftriaxone^^141-2^141-2|||||R|||F|||202002261150
OBX|3|ST|101.000^CFZ^Cefazolin^^76-0^76-0|||||R|||F|||202002261150
OBX|4|ST|500.650^CP^Ciprofloxacin^^185-9^185-9|||||R|||F|||202002261150
OBX|5|ST|600.000^TS^Trimethoprim/sulfamethoxazole^^516-5^516-5|||||R|||F|||202002261150

MSH|^~\&|MIC|RCH|||202002281100||ORU^R01|4177941|D|2.3|||AL|NE
PID|1||RC00007943|RC7677|PHATEST^ITALY^||19991120|M||||||||||RC000767/19|9874855238
OBR|1|39871^MIC|00030065^20:B0000028R^MIC^20:B28^39871|100.5005^BC^Blood culture^^^600-7||202002261205|202002261205|||||||202002261205|Blood^^^Peripheral|||||||||MB|I||||
OBX|1|ST|100.5010^BCT^Blood culture^^6463-4^600-7^S:NG48|1|No growth after 48 hours incubation.||||||P|||202002261217

MSH|^~\&|MIC|SMH|||202002281100||ORU^R01|4177943|D|2.3|||AL|NE
PID|1||SM00047430|RC7677|PHATEST^ITALY^||19991120|M||||||||||SM004230/19|9874855238
OBR|1|39875^MIC|00030069^20:B0000029R^MIC^20:B29^39875|100.5005^BC^Blood culture^^^600-7||202002261236|202002261235|||||||202002261235|Blood^^^Peripheral|||||||||MB|I||||
OBX|1|CE|100.5010^BCT^Blood culture^^6463-4^600-7^O:ECOL|1.1|ECOL^Escherichia coli||||||P|||202002261238
OBX|2|ST|100.5010^BCT^Blood culture^^6463-4^600-7^P:ORGIDSECOM|1.1|||||||P|||202002261238
OBX|3|ST|100.5010^BCT^Blood culture^^6463-4^600-7^R:FSU|1.1|Further susceptibility testing underway.||||||P|||202002261238